Only orlistat (Xenical) has been approved by the FDA for long-term use.
FDA只认可奥利司他(赛尼可)可以长期使用。
Similarly, the FDA is currently reviewing the safety of orlistat because of reports of serious liver injury in people taking it.
同样的,由于发现服用奥利司他会引起严重的肝损伤,FDA近来正在复核使用奥利司他的安全性。
On Thursday, the Public Citizen Health Research Group petitioned the U.S. Food and drug Administration to ban the only approved long-term weight-loss drug, orlistat.
周四,公共市民健康研究机构提请美国食品和药物管理局(FDA)禁止唯一获得批准的长效减肥药奥利斯特。
The group said that orlistat, sold in prescription form as Xenical and over-the-counter as Alli, causes serious side effects such as liver injury and kidney failure.
该机构声称,奥利斯特包括以处方药形式出售的Xenical和非处方药形式出售的Alli,能引发严重的副作用,如肝脏损伤和肾功能衰竭。
After taking orlistat for a year, most people lose about 8.1 kilograms (about 18 pounds). That's about 2.8 kilograms (6 pounds) more than people who take a dummy treatment (a placebo).
服用一年,大部分人体重减轻约8.1公斤(约18磅)。
For orlistat, steatorrhea produces the principal gastrointestinal side effects.
对奥利司他而言,脂肪痢是主要的胃肠道副反应。
The FDA will release its findings on orlistat as soon as the review is completed.
FDA会尽快发布关于奥利司他的再评价结果。
Ovulation rate was 33.3%, 23.35% with orlistat and metformin group respectively, but were not statistically significant.
奥利司他和二甲双胍组的排卵率分别是33.3%和23.35%,但无统计学差异。
The use of orlistat for 1 year in this adolescent population did not raise major safety issues although gastrointestinal adverse events were more common in the orlistat group.
在这些使用奥利司他1年的青少年人群中尽管出现了胃肠道不良反应,但未见其它不安全事件。
The results indicate that administrations of non-cytotoxic concentrations of orlistat reduced the replication of coxsackievirus B3 (CVB3) in different cell types significantly.
结果表明,非细胞毒性浓度的奥利司他减少了柯萨奇病毒B3 (CVB3)在不同的细胞类型的复制。
Between 1999 and 2008, the FDA received 32 reports of serious liver injury in patients taking orlistat. Of those cases, 27 reported hospitalization and six resulted in liver failure.
FDA的公告称,自1999到2008年间,他们共接到32起服用奥利司他的病人出现肝脏损伤的报告,其中的27例进行了住院治疗,6例出现肝功能衰竭迹象。
Conclusion: The use of orlistat during periods of attempted weight maintenance minimizes weight readjustment and facilitates long-term improvement in obesity-related disease risk factors.
结论:在体重的维持期间,奥利司他的使用能够将体重的波动降到最低并能有效改善和肥胖相关的其他风险因子。
Orlistat blocks the digestion and absorption of fat in your stomach and intestines.
奥利司他可以在胃及肠道中阻止脂肪的消化与吸收。
The side effects of over the counter Orlistat include disruption to bowel habits, such as looser stools.
非处方药奥利司他的副作用为排便习惯改变,如排稀便。
Orlistat doesn't stop you feeling hungry, but it stops your body absorbing some of the fat from the food you eat.
奥利司他胶囊,不会让你感觉不饿,但是能阻止身体吸收脂肪。
Objective To study the pathogenesis of non alcoholic fatty liver disease (NAFLD) and the efficacy and safety of Orlistat plus low caroli diet in the treatment of NAFLD.
目的探讨非酒精性脂肪性肝病(NAFLD)的发病机制及奥利司他结合低热量饮食治疗对NAFLD的有效性和安全性。
Objective To study the pathogenesis of non alcoholic fatty liver disease (NAFLD) and the efficacy and safety of Orlistat plus low caroli diet in the treatment of NAFLD.
目的探讨非酒精性脂肪性肝病(NAFLD)的发病机制及奥利司他结合低热量饮食治疗对NAFLD的有效性和安全性。
应用推荐